ABSTRACT
Optimization of the cathode structure and exploration of a novel electrolyte system are important approaches for achieving high-performance zinc-ion batteries (ZIBs) and zinc dendrite suppression. Herein, a quasi-solid-state ZIB combining a sandwich-like MnO2@rGO cathode, a laponite (Lap)-modified polyacrylamide (PAM) hydrogel electrolyte, and an electrodeposited zinc anode is designed and constructed by a synergistic optimization strategy. The MnO2 composite prepared through the intercalation of rGO shows developed mesopores, providing accessible ion transport channels and exhibiting a high electrical conductivity. Thanks to the high dispersion of Lap nanoplates in the hydrogel and good charge-averaging effect, the Zn//PAM-5%Lap//Zn symmetrical battery exhibits a consistent low-voltage polarization of less than 60 mV within 2000 h without a short-circuit phenomenon or any over-potential rise, indicating a stable zinc peeling/plating process. The optimized quasi-solid-state ZIB delivers a high reversible capacity of 291 mA h g-1 at a current density of 0.2 A g-1 due to the synergistic effect of each component of ZIB. Even at a high rate of 2 A g-1, it still maintains a high reversible capacity of 97 mA h g-1 after 2000 cycles, indicating its excellent electrochemical performance. Furthermore, the assembled flexible battery performs excellently in terms of damage and bending resistance.
ABSTRACT
OBJECTIVE: To construct NOD/SCID mouse leukemia model by using THP-1 cells. METHODS: Eighteen female NOD/SCID mice aged 3 to 4 weeks were randomly divided into control group, model group A and model group B (6 in each group). Before inoculation, each mouse was intraperitoneally injected with cyclophosphamide 2 mg/(kg·d) for 2 d, and the mice in model groups were inoculated with cells within 24 h after pretreatment. The mice in model group were inoculated with THP-1 cell suspension in logarithmic growth phase by 1×107 cells/group (group A) and 5×106 cells/group (group B), the mice in the control group were injected with the same amount of normal saline in the tail vein. The general situation was observed, blood routine test and peripheral blood leukocyte classification were performed at 7, 14, 21, 28 d of inoculation before the pre-treatment, and at the time sacrifice. Before dying, tissue of mice were collected and histological examination was performed. RESULTS: Pilereation, droopiness and hypkinesia could be observed from d 7 and d 10 of inoculation cells in model group. Compared with the control group, the body weight of the mice in model group A and B decreased significantly after 21 days of inoculation (P<0.01), and the white blood cell counts increased significantly after 28 days of modeling (P<0.01). Among them, the above-mentioned presentation in inoculation of 1×107 group A was the most significant. Histopathological sections showed diffuse infiltration of leukemia cells in the spleen of the model group. The immunohistochemistry results indicated that the leukemia cells were positive for anti-human CD13, which confirmed the successful establishment of the model. CONCLUSION: After pretreatment with intraperitoneal injection of CTX in NOD/SCID mice, the injection of 1×107 or 5×106 THP-1 cells in tail vein of each mouse can successfully construct an acute myeloid leukemia animal model. The tumor formation is more much faster by injection of high concentration THP-1 cells.